Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival
Sign Up to like & getrecommendations! Published in 2017 at "Leukemia"
DOI: 10.1038/leu.2016.140
Abstract: Immunoparesis is an adverse prognostic marker in plasma cell proliferative disorders. Its impact in AL amyloidosis has not been explored in depth. Newly diagnosed AL amyloidosis patients (n=998) were evaluated for immunoparesis by two methods.… read more here.
Keywords: newly diagnosed; response; diagnosed amyloidosis; amyloidosis ... See more keywords
Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Haematology"
DOI: 10.1111/bjh.16488
Abstract: Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma (MM) is lacking in the current literature. We evaluated 258 patients with relapsed MM, diagnosed from 2008 to 2015, to investigate the prognostic impact of… read more here.
Keywords: characterisation prognostic; immunoparesis; prognostic impact; impact immunoparesis ... See more keywords
Depth of Pre-Treatment Immunoparesis Is an Important Prognostic Factor for Survival in Relapsed Multiple Myeloma
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-123861
Abstract: Background: Suppression of uninvolved immunoglobulins [Ig], or immunoparesis, is associated with an inferior progression-free survival [PFS] and overall survival [OS] in patients with newly diagnosed multiple myeloma [MM]. However, immunoparesis in relapsed MM can be… read more here.
Keywords: first relapse; quantitative immunoparesis; immunoparesis; therapy ... See more keywords